Jarrett Failing

Jarrett Failing

Hematology | Oncology
820 4th St N
Fargo, ND 58102

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients.

Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients.

Journal: Melanoma research
Published: May 15, 2020

Human leukocyte antigen expression in paired primary lung tumors and brain metastases in non-small cell lung cancer.

Human leukocyte antigen expression in paired primary lung tumors and brain metastases in non-small cell lung cancer.

Journal: Cancer immunology, immunotherapy : CII
Published: May 13, 2020

Safety of Influenza Vaccine in Patients With Cancer Receiving Pembrolizumab.

Safety of Influenza Vaccine in Patients With Cancer Receiving Pembrolizumab.

Journal: JCO oncology practice
Published: February 13, 2020

Biomarkers of hyperprogression and pseudoprogression with immune checkpoint inhibitor therapy.

Biomarkers of hyperprogression and pseudoprogression with immune checkpoint inhibitor therapy.

Journal: Future oncology (London, England)
Published: July 13, 2019

Florid dermatopathic lymphadenopathy-A morphological mimic of Langerhans cell histiocytosis.

Florid dermatopathic lymphadenopathy-A morphological mimic of Langerhans cell histiocytosis.

Journal: Clinical case reports
Published: March 15, 2018

Lymphocyte-to-monocyte ratio is associated with survival in pembrolizumab-treated metastatic melanoma patients.

Lymphocyte-to-monocyte ratio is associated with survival in pembrolizumab-treated metastatic melanoma patients.

Journal: Melanoma research
Published: October 11, 2017

Effects of commonly used chronic medications on the outcomes of ipilimumab therapy in patients with metastatic melanoma.

Effects of commonly used chronic medications on the outcomes of ipilimumab therapy in patients with metastatic melanoma.

Journal: Melanoma research
Published: September 08, 2016

61-Year-Old Man With Hypercalcemia and Generalized Lymphadenopathy.

61-Year-Old Man With Hypercalcemia and Generalized Lymphadenopathy.

Journal: Mayo Clinic proceedings
Published: March 31, 2016

35-Year-Old Man With Thrombocytopenia and Generalized Lymphadenopathy.

35-Year-Old Man With Thrombocytopenia and Generalized Lymphadenopathy.

Journal: Mayo Clinic proceedings
Published: February 25, 2015
Showing 1-9 of 9

Last Updated: 09/26/2026